http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004116510-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335 |
| filingDate | 2002-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec381f83485ce8313eeeae067058d112 |
| publicationDate | 2004-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2004116510-A1 |
| titleOfInvention | Antihypertensive agent and cholesterol absorption inhibitor combination therapy |
| abstract | The invention includes methods for treating atherosclerosis and preventing atherosclerotic disease events in a hypertensive patient comprising administering to the patient a therapeutically or prophylactically effective amount of at least one antihypertensive compound in combination with a therapeutically effective amount of a cholesterol absorption inhibitor. The invention also includes a composition comprising at least one antihypertensive compound and a cholesterol absorption inhibitor in therapeutically effective amounts, and a pharmaceutically acceptable carrier. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8414920-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007116756-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013100630-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8226977-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016287558-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010068269-A1 |
| priorityDate | 2002-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 550.